- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Deadline Today for $1B CMS Innovation Challenge
Letters of intent to take part in the CMS Innovation Center's Health Care Innovation Challenge, which promises up to $1 billion for new ideas that improve care, shift incentives and help train a newly-focused healthcare workforce, are due today.
CMS announced the contest, which is aimed at lowering costs for people enrolled in Medicare, Medicaid and CHIP, especially those with the highest health care needs, in November.
.
See also: HHS launches $1B innovation initiative
Anyone wishing to take part in the Health Care Innovation Challenge must first submit a non-binding letter of intent — meant to help CMS determine the expertise and personnel necessary to appropriately review applications and issue awards. Letters are due by 11:59 p.m. Eastern Time on Monday, December 19. Failure to submit one will disqualify the application from that organization from being reviewed during the first round of funding.
On a webinar this past Friday, CMS officials highlighted how the initiative is helping "rubber hit the road" when it comes to health reform, seeking out new and creative ways to design care models and train the health workforce.
The grant funding — with potential awards ranging from $1 million to $30 million is meant to spur creativity as individuals and group "do the hard work" of changing healthcare.
Read the full announcement a:http://healthcareitnews.com/news/deadline-today-1b-cms-innovation-challenge
Source: Healthcare IT News
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More
